All In Biotech

Drug Trial Radar · NCT00934245

Direct and Indirect Protection by Influenza Vaccine Given to Children in India

Last checked: Nov 20, 2026Latest source record: Feb 22, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 4,598 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

4,598

Actual

Start

Sep 2009

Primary completion

Jul 2012

Study completion Jul 2012

Sponsor

Lead sponsor
Wayne Sullender, M.D.Academic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
All India Institute of Medical Sciences; Centers for Disease Control and Prevention
First posted
Jul 8, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The study described here will immunize children with trivalent influenza vaccine (TIV) and determine whether this reduces influenza illness among the immunized children and their older family members. The comparison or control group for the children receiving influenza vaccine will be children immunized with inactivated poliovirus vaccine (IPV). The study will also provide information on the amount of disease produced by influenza in the study population.

Conditions

  • Influenza

Interventions

  • Inactivated Trivalent Influenza VaccineBiological

    Vaccine administration will occur twice, one month apart, in the first year of participation in the study. This will occur as TIV vaccine becomes available in India, in the early autumn. Subsequent years will provide one immunization. Due to the inclusion of the pandemic 2009 influenza A H1N1 virus in the 2010-2011 northern hemisphere vaccine formulation and recommendations that children should receive 2 doses of this vaccine this study will administer 2 doses of vaccine in the second year of the study.

  • Inactivated polio vaccine (IPV)Biological

    Vaccine administration will occur twice, one month apart, in the first year of participation in the study to parallel administration of TIV (experimental intervention). Subsequent years will provide one immunization except 2011 schedule modified to accommodate changes in TIV schedule as per above..

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Laboratory-confirmed influenza infection in vaccinated childTime frame: 1 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Comprehensive Rural Health Services Project (CRHSP)

    Ballabgarh, Haryana, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.